Literature DB >> 31047723

Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling.

Geeske van Rooijen1, Maaike van Rooijen2, Arija Maat3, Jentien M Vermeulen4, Carin J Meijer5, Henricus G Ruhé6, Lieuwe de Haan7, Behrooz Z Alizadeh8, Agna A Bartels-Velthuis9, Nico J van Beveren10, Richard Bruggeman11, Wiepke Cahn12, Philippe Delespaul13, Inez Myin-Germeys14, Rene S Kahn15, Frederike Schirmbeck16, Claudia J P Simons17, Therese van Amelsvoort18, Neeltje E van Haren19, Jim van Os20, Ruud van Winkel21.   

Abstract

Patients diagnosed with schizophrenia often report a low quality of life (QoL). The purpose of this study was to investigate whether we could replicate a cross-sectional model by Alessandrini et al. (2016, n = 271) and whether this model predicts QoL later in life. This model showed strong associations between schizophrenia spectrum symptoms and depressive symptoms on QoL, but lacked follow-up assessment. This model was adapted in the current study and the robustness was investigated by using a longitudinal design in which the association between baseline variables (including IQ, depression, schizophrenia spectrum symptoms as well as social functioning) and QoL during 3-years of follow-up was investigated. We included patients with a non-affective psychotic disorder (n = 744) from a prospective naturalistic cohort-study. In the cross-sectional model, with good measure of fit, both depression as well as social functioning was associated with QoL (direct path coefficient -0.28 and 0.41, respectively). Additionally, the severity of schizophrenia spectrum symptoms was highly associated with social functioning (direct path coefficient -0.70). Importantly, the longitudinal model showed good measures of fit, which strengthens the validity of the initial model and highlights that depression prospectively affect QoL while schizophrenia spectrum symptoms prospectively influence QoL via social functioning. The negative, longitudinal impact of a depression on QoL highlights the need to focus on treatment of this co-morbidity.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Year:  2019        PMID: 31047723     DOI: 10.1016/j.schres.2019.04.011

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  Affective lability and social functioning in severe mental disorders.

Authors:  Margrethe Collier Høegh; Ingrid Melle; Sofie R Aminoff; Stine Holmstul Olsen; Synve Hoffart Lunding; Torill Ueland; Trine Vik Lagerberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-01-27       Impact factor: 5.760

2.  Modeling the Longitudinal Effects of Insight on Depression, Quality of Life and Suicidality in Schizophrenia Spectrum Disorders: Results from the FACE-SZ Cohort.

Authors:  Mickaël Ehrminger; Mathieu Urbach; Christine Passerieux; Bruno Aouizerate; Fabrice Berna; Anne-Lise Bohec; Delphine Capdevielle; Isabelle Chereau; Julie Clauss; Caroline Dubertret; Aurélie Esselin; Catherine Faget; Guillaume Fond; Roxana Mihaela Honciuc; Marine Jarroir; Jasmina Mallet; David Misdrahi; Baptiste Pignon; Romain Rey; Franck Schürhoff; Hanan Yazbek; Eric Brunet-Gouet; Paul Roux
Journal:  J Clin Med       Date:  2019-08-10       Impact factor: 4.241

3.  Deriving symptom networks from digital phenotyping data in serious mental illness.

Authors:  Ryan Hays; Matcheri Keshavan; Hannah Wisniewski; John Torous
Journal:  BJPsych Open       Date:  2020-11-03

4.  Quality of life in patients with schizophrenia: A 2-year cohort study in primary mental health care in rural China.

Authors:  Xiao-Yan He; Christine Migliorini; Zhuo-Hui Huang; Fei Wang; Rui Zhou; Zi-Lang Chen; Yao-Nan Xiao; Qian-Wen Wang; Shi-Bin Wang; Carol Harvey; Cai-Lan Hou
Journal:  Front Public Health       Date:  2022-09-07

5.  Relationship of subjective quality of life with symptomatology, neurocognition and psychosocial functioning in first-episode psychosis: a structural equation modelling approach.

Authors:  Sandra Chi Yiu Wong; Wing Chung Chang; Christy Lai Ming Hui; Sherry Kit Wa Chan; Edwin Ho Ming Lee; Yi Nam Suen; Eric Yu Hai Chen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-07-25       Impact factor: 5.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.